Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

References for PMC Articles for PubMed (Select 22436213)

1.

Pilot study of resveratrol in older adults with impaired glucose tolerance.

Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P, Hawkins M, Cohen HW, Barzilai N.

J Gerontol A Biol Sci Med Sci. 2012 Dec;67(12):1307-12. doi: 10.1093/gerona/glr235. Epub 2012 Jan 4.

2.

Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?

Cantó C, Auwerx J.

Pharmacol Rev. 2012 Jan;64(1):166-87. doi: 10.1124/pr.110.003905. Epub 2011 Nov 21. Review.

3.

Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.

Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, Moonen-Kornips E, Hesselink MK, Kunz I, Schrauwen-Hinderling VB, Blaak EE, Auwerx J, Schrauwen P.

Cell Metab. 2011 Nov 2;14(5):612-22. doi: 10.1016/j.cmet.2011.10.002.

4.

Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila.

Burnett C, Valentini S, Cabreiro F, Goss M, Somogyvári M, Piper MD, Hoddinott M, Sutphin GL, Leko V, McElwee JJ, Vazquez-Manrique RP, Orfila AM, Ackerman D, Au C, Vinti G, Riesen M, Howard K, Neri C, Bedalov A, Kaeberlein M, Soti C, Partridge L, Gems D.

Nature. 2011 Sep 21;477(7365):482-5. doi: 10.1038/nature10296.

5.

Challenges of translating basic research into therapeutics: resveratrol as an example.

Smoliga JM, Vang O, Baur JA.

J Gerontol A Biol Sci Med Sci. 2012 Feb;67(2):158-67. doi: 10.1093/gerona/glr062. Epub 2011 Jul 11.

6.

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol.

Vang O, Ahmad N, Baile CA, Baur JA, Brown K, Csiszar A, Das DK, Delmas D, Gottfried C, Lin HY, Ma QY, Mukhopadhyay P, Nalini N, Pezzuto JM, Richard T, Shukla Y, Surh YJ, Szekeres T, Szkudelski T, Walle T, Wu JM.

PLoS One. 2011;6(6):e19881. doi: 10.1371/journal.pone.0019881. Epub 2011 Jun 16. Review.

7.

Resveratrol and health--a comprehensive review of human clinical trials.

Smoliga JM, Baur JA, Hausenblas HA.

Mol Nutr Food Res. 2011 Aug;55(8):1129-41. doi: 10.1002/mnfr.201100143. Epub 2011 Jun 20. Review.

PMID:
21688389
8.

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

Brasnyó P, Molnár GA, Mohás M, Markó L, Laczy B, Cseh J, Mikolás E, Szijártó IA, Mérei A, Halmai R, Mészáros LG, Sümegi B, Wittmann I.

Br J Nutr. 2011 Aug;106(3):383-9. doi: 10.1017/S0007114511000316. Epub 2011 Mar 9.

PMID:
21385509
9.

A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal.

Ghanim H, Sia CL, Korzeniewski K, Lohano T, Abuaysheh S, Marumganti A, Chaudhuri A, Dandona P.

J Clin Endocrinol Metab. 2011 May;96(5):1409-14. doi: 10.1210/jc.2010-1812. Epub 2011 Feb 2.

10.

Clinical trials of resveratrol.

Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K.

Ann N Y Acad Sci. 2011 Jan;1215:161-9. doi: 10.1111/j.1749-6632.2010.05853.x. Review.

PMID:
21261655
11.

Resveratrol and life extension.

Agarwal B, Baur JA.

Ann N Y Acad Sci. 2011 Jan;1215:138-43. doi: 10.1111/j.1749-6632.2010.05850.x. Review.

PMID:
21261652
12.
13.

Resveratrol commonly displays hormesis: occurrence and biomedical significance.

Calabrese EJ, Mattson MP, Calabrese V.

Hum Exp Toxicol. 2010 Dec;29(12):980-1015. doi: 10.1177/0960327110383625. Review.

PMID:
21115559
14.

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.

Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE.

Cancer Res. 2010 Nov 15;70(22):9003-11. doi: 10.1158/0008-5472.CAN-10-2364. Epub 2010 Oct 8.

15.

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K.

Cancer Res. 2010 Oct 1;70(19):7392-9. doi: 10.1158/0008-5472.CAN-10-2027. Epub 2010 Sep 14.

16.

Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.

Chow HH, Garland LL, Hsu CH, Vining DR, Chew WM, Miller JA, Perloff M, Crowell JA, Alberts DS.

Cancer Prev Res (Phila). 2010 Sep;3(9):1168-75. doi: 10.1158/1940-6207.CAPR-09-0155. Epub 2010 Aug 17.

17.

Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.

Wong RH, Howe PR, Buckley JD, Coates AM, Kunz I, Berry NM.

Nutr Metab Cardiovasc Dis. 2011 Nov;21(11):851-6. doi: 10.1016/j.numecd.2010.03.003. Epub 2010 Jul 31.

PMID:
20674311
18.

AMP-activated protein kinase and its downstream transcriptional pathways.

Cantó C, Auwerx J.

Cell Mol Life Sci. 2010 Oct;67(20):3407-23. doi: 10.1007/s00018-010-0454-z. Epub 2010 Jul 17. Review.

19.

Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity.

Dal-Pan A, Blanc S, Aujard F.

BMC Physiol. 2010 Jun 22;10:11. doi: 10.1186/1472-6793-10-11.

20.

An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol.

Ghanim H, Sia CL, Abuaysheh S, Korzeniewski K, Patnaik P, Marumganti A, Chaudhuri A, Dandona P.

J Clin Endocrinol Metab. 2010 Sep;95(9):E1-8. doi: 10.1210/jc.2010-0482. Epub 2010 Jun 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk